REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Hinova Pharmaceuticals Inc. (China)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Hinova Pharmaceuticals Inc. Profile Updated: December 22, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Hinova Pharmaceuticals Inc. is an innovative pharmaceutical company engaged in cancer and metabolic diseases. The main products of company include pharmaceuticals for cancer and metabolic diseases. The company was established in 2013 and is headquartered in Chengdu, Sichuan Province.

Headquarters
No. 2 and 3, 4th Floor, Building 1, Rongyao Building, No. 5, Keyuan South Road, High-tech Zone, Chengdu, Sichuan Province
Chengdu; Sichuan; Postal Code: 610041

Contact Details: Purchase the Hinova Pharmaceuticals Inc. report to view the information.

Website: http://www.hinovapharma.com

Basic Information
Total Employees:
Purchase the Hinova Pharmaceuticals Inc. report to view the information.
Outstanding Shares:
Purchase the Hinova Pharmaceuticals Inc. report to view the information.
Registered Capital:
Purchase the Hinova Pharmaceuticals Inc. report to view the information.
Financial Auditors:
Purchase the Hinova Pharmaceuticals Inc. report to view the information.
Incorporation Date:
February 05, 2013
Key Executives
Purchase this report to view the information.
Chairman of the Supervisory Board
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
General Manager
Purchase this report to view the information.
Independent Director
Ownership Details
Purchase this report to view the information.
13.26%
Purchase this report to view the information.
10.62%
Purchase this report to view the information.
3.87%
Purchase this report to view the information.
3.66%
Purchase this report to view the information.
3.63%
Company Performance
Financial values in the chart are available after Hinova Pharmaceuticals Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Total operating revenue
-44.99%▼
Operating profit (EBIT)
35.28%▲
Net Profit (Loss) for the Period
35.28%▲
Total assets
-10.85%▼
Total equity
-12.29%▼
Return on Equity (ROE)
4.44%▲
Quick Ratio
-1.85%▼
Cash Ratio
-1.55%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo